Chlamydia infection screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2], Aysha Anwar, M.B.B.S[3]

According to the CDC's 2015 Sexually Transmitted Diseases Treatment Guidelines, screening for chlamydia is recommended for sexually active women under 25 years, women over 25 who are at increased risk, all pregnant women under 25 years, pregnant women over 25 who are at increased risk, men who have sex with men, and individuals with HIV.^[1][2]

According to the CDC's 2015 Sexually Transmitted Diseases Treatment Guidelines, screening for chlamydia is recommended. The guidelines are as follows:^[1][2]

• Sexually active women under 25 years of age
• Sexually active women aged 25 years and older if at increased risk
• Retest approximately 3 months after treatment if necessary

• All pregnant women under 25 years of age
• Pregnant women aged 25 and older if at increased risk
• Retest during the 3rd trimester for women under 25 years of age or at risk

• Consider screening young men in high-prevalence clinical settings or in populations with high burden of infection (e.g., MSM)
• At least annually for sexually active men who have sex with men (MSM) and then every 3 to 6 months if at increased risk

• For sexually active individuals, screen at first HIV evaluation and at least annually thereafter
• More frequent screening might be appropriate depending on individual risk behaviors and local epidemiology

Template:WikiDoc Sources